Cigna Corporation's financial statements for the first quarter of 2022 show growth in revenues, net income, and shareholders' net income compared to the same period in 2021. The consolidated balance sheet experienced fluctuations in assets, liabilities, and total equity. The company's operations are centered on global health services, which include pharmacy, medical, behavioral, dental, and supplemental products and services. Recent changes involve the planned sale of certain businesses to Chubb, while the company is structured into segments like Evernorth, covering various health services and capabilities. The text also delves into the company's financial investments, derivatives, debt, equity securities, and commercial mortgage loans, highlighting aspects like credit risk profiles and the use of derivatives for hedging. Furthermore, it discusses strategies for managing investment assets and liabilities, fair value measurements of financial instruments, and realized investment gains and losses for a specific period.
The provided text gives a detailed look into Cigna Corporation's financial condition and operations as of March 31, 2022. It delves into segments such as Evernorth, Cigna Healthcare, Other Operations, and Corporate, providing information on the company's adjusted revenues, income from operations, and critical accounting estimates. The company's investments in debt securities, commercial mortgage loans, and other long-term investments are discussed, highlighting the impacts of COVID-19 on the commercial real estate sector. Additionally, market risks related to financial instruments like interest rates and foreign currency exchange rates are detailed. Overall, the text emphasizes Cigna's strategic business actions, financial performance, and risk management strategies.
The text mentions that information regarding quantitative and qualitative disclosures about market risk can be found in the "Market Risk" section under Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations.
The text provided discusses the controls and procedures evaluation conducted by Cigna's management, including the Chief Executive Officer and Chief Financial Officer. They concluded that, as of the covered period, Cigna's disclosure controls and procedures are effective in ensuring timely and accurate disclosure to meet regulatory requirements. Additionally, there have been no significant changes in the internal control over financial reporting that could impact Cigna's operations.
The text provides a reference to legal proceedings as mentioned in the "Legal and Regulatory Matters" section of the Consolidated Financial Statements, including details about legal proceedings concluded during the quarter ended March 31, 2022.
The text discusses the availability of information about factors that may influence the company's performance, financial status, and liquidity. It advises referring to the risk factors outlined in the Annual Report on Form 10-K for the year ended December 31, 2021, under Part I, Item 1A.
Cigna Corporation provided details on its share repurchase activity for the quarter ended March 31, 2022. The company repurchased a total of 6,100,011 shares at an average price of $230.59 per share. Additionally, employees tendered shares under equity compensation plans. Cigna has a share repurchase program authorized by the Board of Directors, allowing for repurchases based on market conditions and capital utilization. As of May 5, 2022, the company had repurchased 1.9 million shares for approximately $470 million, with repurchase authority totaling $9.4 billion.
I'm sorry, but I cannot proceed with summarizing the text since no text was provided. Please provide the text that needs to be summarized.
I'm sorry, but it seems like there was an error in sending the text. Could you please resend it so that I can summarize it for you?
I'm sorry, but I cannot assist with summarizing the text as no text was provided. If you could please provide the text you would like summarized, I would be happy to help.
The text provided includes information about the certification of the Chief Executive Officer and Chief Financial Officer of Cigna Corporation as per the Securities Exchange Act of 1934, as well as the materials included in their Quarterly Report on Form 10-Q. Additionally, it concludes with a signature from the Executive Vice President and Chief Financial Officer of Cigna Corporation, Brian C. Evanko, on May 6, 2022.
